Université Paris Cité Inserm IAME 1137, 75018, Paris, France.
Infection Control Program and WHO Collaborating Centre, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
Intensive Care Med. 2024 Jul;50(7):1108-1118. doi: 10.1007/s00134-024-07498-1. Epub 2024 Jun 24.
This study aimed to evaluate the impact on subsequent infections and mortality of an adequate antimicrobial therapy within 48 h after catheter removal in intensive care unit (ICU) patients with positive catheter tip culture.
We performed a retrospective analysis of prospectively collected data from 29 centers of the OUTCOMEREA network. We developed a propensity score (PS) for adequate antimicrobial treatment, based on expert opinion of 45 attending physicians. We conducted a 1:1 case-cohort study matched on the PS score of being adequately treated. A PS-matched subdistribution hazard model was used for detecting subsequent infections and a PS-matched Cox model was used to evaluate the impact of antibiotic therapy on mortality.
We included 427 patients with a catheter tip culture positive with potentially pathogenic microorganisms. We matched 150 patients with an adequate antimicrobial therapy with 150 controls. In the matched population, 30 (10%) subsequent infections were observed and 62 patients died within 30 days. Using subdistribution hazard models, the daily risk to develop subsequent infection up to Day-30 was similar between treated and non-treated groups (subdistribution hazard ratio [sHR] 1.08, 95% confidence interval [CI] 0.62-1.89, p = 0.78). Using Cox proportional hazard models, the 30-day mortality risk was similar between treated and non-treated groups (HR 0.89, 95% CI 0.45-1.74, p = 0.73).
Antimicrobial therapy was not associated with decreased risk of subsequent infection or death in short-term catheter tip colonization in critically ill patients. Antibiotics may be unnecessary for positive catheter tip cultures.
本研究旨在评估在重症监护病房(ICU)患者导管尖端培养阳性的情况下,在导管拔出后 48 小时内进行适当的抗菌治疗对随后感染和死亡率的影响。
我们对 OUTCOMEREA 网络的 29 个中心前瞻性收集的数据进行了回顾性分析。我们根据 45 名主治医生的专家意见,为适当的抗菌治疗制定了倾向评分(PS)。我们进行了 1:1 的病例-队列研究,根据 PS 评分进行匹配,以确定是否接受了适当的治疗。使用 PS 匹配的亚分布风险模型检测随后的感染,使用 PS 匹配的 Cox 模型评估抗生素治疗对死亡率的影响。
我们纳入了 427 例导管尖端培养阳性的患者,其中有潜在致病性微生物。我们匹配了 150 例接受适当抗菌治疗的患者和 150 例对照组患者。在匹配人群中,观察到 30 例(10%)随后感染,30 天内有 62 例患者死亡。使用亚分布风险模型,在第-30 天之前,治疗组和未治疗组发生随后感染的每日风险相似(亚分布风险比 [sHR] 1.08,95%置信区间 [CI] 0.62-1.89,p=0.78)。使用 Cox 比例风险模型,治疗组和未治疗组的 30 天死亡率相似(HR 0.89,95%CI 0.45-1.74,p=0.73)。
在 ICU 患者短期导管尖端定植的情况下,抗菌治疗与随后感染或死亡风险降低无关。对于阳性导管尖端培养,抗生素可能不是必需的。